A carregar...
Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used to treat non-small cell lung cancer (NSCLC) because they inhibit tumour growth and metastasis. However, the underlying mechanisms are not fully understood. Here, we investigate whether anti-lymphangiogene...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930403/ https://ncbi.nlm.nih.gov/pubmed/31892990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.35448 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|